Recurrent aphthous stomatitis: Bibliographic review

Revista Brasileira de Otorrinolaringologia

Volumn 68, Issue 4, 2002, Pages 571-578

  Fraiha, Paula M ^a   Bittencourt, Patrícia G ^a   Celestino, Leandro R ^a  

^a NONE

Author keywords

Aphthous stomatitis; Oral lesions; Ulcers

Indexed keywords

ALPHA2 INTERFERON; AMINOSALICYLIC ACID 5; AMINOSALICYLIC ACID DERIVATIVE; AMLEXANOX; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BENZYDAMINE; CARBENOXOLONE; CHLORHEXIDINE; CIMETIDINE; CLOBETASOL; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; DEXAMETHASONE; FLUONAMIDE; HALBETASOLE; IMMUNOMODULATING AGENT; LIDOCAINE; PENTOXIFYLLINE; PROSTAGLANDIN E2; STEROID; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGRANULOCYTOSIS; APHTHOUS STOMATITIS; BITTER BREATH; BURNING SENSATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DENTAL SPOT; DISEASE ASSOCIATION; DISEASE DURATION; DRUG INDUCED DISEASE; DYSGEUSIA; DYSPHAGIA; FERTILITY; HALITOSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOGENETICS; INSOMNIA; LIBIDO DISORDER; MEDICAL LITERATURE; NAUSEA; NEUROPATHY; NEUTROPENIA; ODYNOPHAGIA; PAIN; PHARYNX BURNING SENSATION; PUBLICATION; RASH; REVIEW; RISK FACTOR; SCAR; SEDATION; TERATOGENICITY; THRUSH; TOOTH DISEASE; ULCER HEALING; VERTIGO;

EID: 0036665646     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992002000400019     Document Type: Review

References (51)

1. Amador VAR, Pedraza LE, Topete RO. Frequency of oral conditions in a dermatology clinic. International journal of Dermatology 2000;39:501-05.
2. Axell C & Henricsson V. Association between recurrent aphthous ulcers and tobacco habits. Journal of Dental Research 1985;93:239-42.
3. Baughman RA. Recurrent aphthous stomatitis vs. recurrent herpes: do you know the difference? J Ala Dent Assoc 1996;80(1):26-32.
4. Boulinguez S, Cornee-Leplat I, Bouyssou-Gauthier ML, Bedane C, Bonnetblanc JM. Analysis of the literature about drug-induced aphthous ulcers. Ann Dermatol Venereol 2000;127(2):155-58.
5. Burruano F, Tortorici S. Stomatite aftosa major (malattia di Sutton). Etiopatogenesi, quadri istologici ed aspetti clinici. Minerva Stomatol 2000;49(1-2):41-50.
6. Calabrese L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000;108(6):487-95.
7. Carpenter WM, Silverman S. Over-the-counter products for oral ulcerations. J Calif Dent Assoc 1998 Mar;26(3):199-201.
8. Chung JY, Ramos-Caro FA, Ford MJ, Mullins D. Recurrent scarring ulcers of the oral mucosa. Sutton disease (periadenitis mucosa necrotica recurrens). Arch. Dermatol. 1997 Sep;133(9):1162-3, 1165-6.
9. Claessen FA, Vos MJ, Simoons-Smit AM, Debets-Ossenkopp YJ, Perenboom RM. Manifestaties van histoplasmose. Ned Tijdschr Geneeskd 2000;144(25):1201-5.
10. Eversole LR. Diseases of the oral mucous membranes In. Millard D & Mason DK (eds.) World Workshop on Oral Medicine. Chicago: Year Publishes; 1989. p.54-121.
11. Eversole LR. Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Seminars in Cutaneous Medicine and Surgery 1997;16(4):284-294.
12. Feder HM. Periodic fever, aphthous stomatitis, adenitis: a clinical review of a new syndrome. Curr Opin Pediatr 2000;12(3):253-6.
13. Ficarra G. Oral ulcers in HIV-infected patients: an update on epidemiology and diagnosis. Oral Disease 1997 may;3 suppl 1:s183-9.
14. Filho ACNN, Bettega SG, Lunedo S, Gortz F, Maestri JE, Abicalaffe MD. Estomatite Aftóide Recidivante: Revisão e Proposta de Protocolo no seu Atendimento. Arquivos da Fundação Otorrinolaringologia 1999;3(4):172-6.
15. Frances C. Dermato-mucosal manifestations of Behcet's disease. Ann Med Interne 1999 nov;150(7):535-41.
16. Greenspan D, Greenspan JS. HIV-related oral disease. Lancet 1996;348(9029):729-33.
17. Guranska N, Urbaniak B, Lewkowicz P, Tchorzewski H. Recurrent aphthous ulcers: the etiology with special reference to immunological theories. Pol Merkuriusz Lek 2000;8(44):113-17.
18. Heft M & Wray D. Anxiety levels in recurrent aphthous stomatitis (RAS) patients. Journal of Dental Research 1982;39:212-18.
19. Hornstein OP. Aphthae and aphthous lesions of the mouth mucosa. HNO 1998;46(2):102-11.
20. Lacosta Nicolas JL, Martinez Iniguez JC. Treatment of recurrent aphthous stomatitis: A bibliographic review. Rev Clin Esp 1998;198(4):234-36.
21. Lehner T. Progress report: oral ulceration and Behcet's syndrome. Gut 1977;18:491-511.
22. MacPhail, L. Topical and Systemic Therapy for Recurrent Aphthous Stomatitis. Seminars in Cutaneous Medicine and Surgery 1997;16(4):301-7.
23. Macphail LA, Greespan JS. Oral ulceration in HIV infection: investigation and pathogenesis. Oral Disease 1997 may;3(suppl 1):s190-3.
24. Mcbride DR. Management of aphthous ulcers. Am Physician 2000;62(1):149-54, 160.
25. Mccullough MJ, Firth NA, Reade PC. Human immunodeficiency virus infection: a review of mode of infection, pathogenesis, disease course, and the general and clinical manifestations. Aust Dent J 1997 feb;42(1):30-7.
26. Medina LM, Rubio JLC, Garcia ET, Centeno NO. Utility of HLA Typing in the Differential Diagnosis of Severe Aphthosis and Behcet's disease. Dermatology 2000;280-1.
27. Miziara ID. Estomatite Aftóide Recidivante. Revista Brasileira de Otorrinolaringologia 1995;61(5):418.
28. Murray LN, Amedee RG. Recurrent aphthous stomatitis. J La State Med Soc 2000 jan;152(1):10-4.
29. Petersen MJ, Baughman RA. Recurrent aphthous stomatitis: primary care management. Nurse Pract 1996 may;21(5):36-40, 42, 47.
30. Popovski J, Camisa C. New and emerging therapies for diseases of the oral cavity. Dermatologic clinics 2000;18(1):113-25.
31. Porter SR, Hegarty A, Kaliakatsouu F, Hodgson TA, Scully C. Recurrent Aphthous Stomatitis. Clinics in Dermatology 2000;18:569-578.
32. Porter SR & Scully C. Aphthous stomatitis - an overview of aetiopathogenesis and management. Clinical and Experimental Dermatology 1991;16;235-43.
33. Porter SR & Scully C. Primary immunodeficiency. In: Jones JH & Mason DK (eds.) Oral Manifestations of Systemic Disease. London: Balliere Tindall; 1990. p.112-62.
34. Porter SR, Scully C, Flint SR. Haematological status in recurrent aphthous stomatitis compared with other oral disease. Oral Surgery, Oral Medicine, Oral Pathology 1988;66:41-4.
35. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit. Rev. Oral Bil. Med 1998;9(3):306-321.
36. Rees TD, Binnie WH. Recurrent aphthous stomatitis. Dermatol Clin 1996 apr;14(2):243-56.
37. Reichart PA. Oral ulcerations in HIV infection. Oral Disease 1997 may;3(1 suppl):s180-2.
38. Rogers III RS. Recurrent Aphthous Stomatitis: Clinical Characteristics and Associated Systemic Disorders. Seminars in Cutaneous Medicine and Surgery 1997;16(4):278-83.
39. Rogers III RS. Recurrent Aphthous Stomatitis: Clinical Characteristics and Evidence for an Immunopathogenesis. The Journal of Investigative Dermatology 1977;69:499-509.
40. Rogers III RS. Recurrent aphthous stomatitis in the diagnosis of Behcet's disease. Yonsei Med J 1997 dec;38(6):370-379.
41. Scully C, Porter SR. Aphthous Stomatitis: an overview of aetiopathogenesis and management. Clinical and Experimental Dermatology 1991;16:235-43.
42. Scully C, Yap P, Boyle P. IgE and IgD concentrations in patients with recurrent aphthous stomatitis. Arch Dermatol 1983;(119):31-4.
43. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996 feb;81(2):141-47.
44. Siegel MA. Strategies for management of commonly encountered oral mucosal disorders. J Calif Dent Assoc 1999;27(3):210-12, 215,218-19 passim.
45. Silva MR, Fernandes NC. Afecções das Mucosas e Semimucosas. JBM 2001;80(3):50-66.
46. Torras H, Lecha M, Mascaro JM. Thalidomide in the Treatment of Recurrent, Necrotic, and Giant Mucocutaneous Aphthae and Aphthosis. Arch Dermatol 1979;115:636-37.
47. Tüzün B, Tüzün Y, Wolf R. Oral Disorders: Unapproved Treatments or Indications. Clinics in Dermatology 2000;18:197-200.
48. Ueta E, Umazume M, Yamamoto T, Osaki T. Leukocyte dysfunction in oral mucous membrane diseases. J Oral Pathol Med 1993;(22):120-5.
49. Weidle PJ. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus. Am J Health Syst Pharm 1996 feb;53(4):368, 371-2, 378.
50. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dent Assoc 1996 aug;127(8):1202-13.
51. Wormser GP, Mack L, Lenox T et. al. Lack of effect of oral acyclovir on prevention of aphthous stomatitis. Otolaryngology and Head and Neck Surgery 1988;98:14-7.